InvestSMART

Polynovo Limited (ASX:PNV)

ALERT: Price-sensitive ASX Announcement for PNV
Current share price for PNV : $0.865 -0.128 (-12.85%)+
Announcement
Release
20 Feb 2026 11:34AM
Price at Release
$0.993
Full Release
download
Summary
PolyNovo Limited presented its 1H FY26 results, showcasing significant growth in sales and strategic advancements. The company's total group sales reached A$68.2 million, marking a 26.0% increase from the previous year. Notably, U.S. sales were a major contributor, with A$51.7 million, reflecting a 25.3% increase. NovoSorb MTX sales saw remarkable growth of 195.2% to A$6.2 million. The rest of the world also exhibited strong sales growth, particularly in markets like Turkey, Australia, and Canada. PolyNovo's strategic focus on expanding its NovoSorb technology platform, geographic presence, and product indication continues, including the preparation for a U.S. PMA submission for NovoSorb BTM for full-thickness burns. They experienced a reduction in debtor days and reported a positive cash flow from operations. The company is well-positioned for future growth with a strong balance sheet and continued investment in manufacturing and R&D capabilities.
Key Points
  • Group sales rose to A$68.2 million, a 26.0% increase.
  • U.S. sales contributed A$51.7 million, up 25.3%.
  • NovoSorb MTX sales increased by 195.2% to A$6.2 million.
  • Significant sales growth in Turkey, Australia, and Canada.
  • Preparation for U.S. PMA submission for NovoSorb BTM.
  • Positive cash flow from operations and reduced debtor days.
  • Continued investment in manufacturing and R&D capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.